What is the long-term trend for Beneficient's indefinite-lived research and development assets?

Over 3 years (2022 to 2025), Beneficient's indefinite-lived research and development assets has grown at a 0.0% compound annual growth rate (CAGR), from $3.1M to $3.1M.

Beneficient BENF Indefinite-Lived Research and Development Assets

Indefinite-Lived Research and Development Assets at other companies

LPL Financial HoldingsLPLA

$2.06M-90.7%

Other financials

Income statement

See full

Revenue$18.7M+322%

Operating income$3.9M+141%

Net income$19.9M+331%

EPS (diluted)-$0.49+26.5%

Balance sheet

See full

Cash & equivalents$7.9M+87.3%

Total debt$100.3M-16.6%

Total equity-$128.6M-1,002%

Total assets$337.9M-15.5%

Cash flow

See full

Operating cash flow-$9.4M+6.3%

CapEx$96.0K-85.5%

Free cash flow-$9.4M+6.7%

Valuation

See full

Market cap$52.86M+2,018%

Enterprise value$145.33M+40.6%

Profitability

See full

Operating margin548.5%-323pp

Net margin517.9%-235pp

FCF margin156.8%-40.4pp

Returns & leverage

See full

Return on equity-1,647.1%-2,080pp

Debt / equity8.4×-23.8×

Where this comes from

Reported directly by Beneficient in its filing.

Tagged under the XBRL concept us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill.

The official record: Beneficient’s 10-Q, filed February 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beneficient's indefinite-lived research and development assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Beneficient's indefinite-lived research and development assets?: Beneficient (BENF) reported indefinite-lived research and development assets of $3.1M in Q4 2025.
What is the long-term trend for Beneficient's indefinite-lived research and development assets?: Over 3 years (2022 to 2025), Beneficient's indefinite-lived research and development assets has grown at a 0.0% compound annual growth rate (CAGR), from $3.1M to $3.1M.